AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)
AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by subcutaneous route marketed mainly as human prescription drug products.
About AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)
AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Janssen Biotech, Inc.. In this ingredient’s product set, the most common route of administration is subcutaneous. Approved labelling for these products most frequently references: egfr exon, treatment adult, locally advanced, metastatic nsclc, substitution mutations, detected fda-approved, rybrevant faspro, see dosage. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
How it is supplied
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | SUBCUTANEOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Janssen Biotech, Inc. | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| Rybrevant Faspro | Janssen Biotech, Inc. | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
Frequently asked questions
How many FDA drug products contain AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)?
1 FDA drug label records list AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) products?
The manufacturers with the most AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) label records are Janssen Biotech, Inc.. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.